Propel Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROPEL PHARMA, and what generic and branded alternatives to PROPEL PHARMA drugs are available?
PROPEL PHARMA has two approved drugs.
Drugs and US Patents for Propel Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Propel Pharma | VIGABATRIN | vigabatrin | FOR SOLUTION;ORAL | 213390-001 | Jul 29, 2021 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Propel Pharma | VIGABATRIN | vigabatrin | TABLET;ORAL | 215519-001 | Apr 28, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.